Prescription Drugs market research reports by DelveInsight

• Opioid Overdose - Pipeline Insight, 2024

  Aug 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Opioid Overdose - Pipeline Insight, 2024 DelveInsight’s, “Opioid Overdose- Pipeline Insight, 2024” report provides comprehensive insights about 6+ companies and 6+ pipeline drugs in Opioid Overdose pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage pro ... Read More

• Opioid Overdose – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Opioid Overdose – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Opioid Overdose – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Opioid Overdose, historical and forecasted epidemiology as well as the Opioid Ove ... Read More

• Opioid Dependence – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Opioid Dependence – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Opioid Dependence – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Opioid Dependence, historical and forecasted epidemiology as well as the Opio ... Read More

• Eosinophilic Asthma – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Eosinophilic Asthma – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Eosinophilic Asthma – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Eosinophilic Asthma, historical and forecasted epidemiology as well as th ... Read More

• Opioid-Induced Constipation – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Opioid-Induced Constipation – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Opioid-Induced Constipation – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Opioid-Induced Constipation, historical and forecasted ep ... Read More

• Helicobacter Pylori Infection - Pipeline Insight, 2024

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Helicobacter Pylori Infection - Pipeline Insight, 2024 DelveInsight’s, “Helicobacter Pylori Infection - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Helicobacter Pylori Infection pipeline landscape. It covers the pipeline drug profiles, ... Read More

• Tuberculosis – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Tuberculosis – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Tuberculosis – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Tuberculosis, historical and forecasted epidemiology as well as the Tuberculosis market ... Read More

• Opium Addiction – Market Insight, Epidemiology, and Market Forecast – 2034

  Jun 01, 2024  |  Published by: DelveInsight  |  USD 7,950

  Opium Addiction – Market Insight, Epidemiology, and Market Forecast – 2034 DelveInsight's ""Opium Addiction – Market Insights, Epidemiology, and Market Forecast – 2034"" report delivers an in-depth understanding of the Opium Addiction, historical and forecasted epidemiology as well as the Opium Addi ... Read More

• Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024 “Serotonin Reuptake Inhibitor (SRI) - Pipeline Insight, 2024” report by DelveInsight offers comprehensive insights of the pipeline (under development) therapeutics scenario and growth prospects across Serotonin Reuptake Inhibitor (SRI) deve ... Read More

• Complicated Urinary Tract Infections - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,500

  Complicated Urinary Tract Infections - Pipeline Insight, 2024 DelveInsight’s, “Complicated Urinary Tract Infections – Pipeline Insight, 2024,” report provides comprehensive insights about 12+ companies and 12+ pipeline drugs in Complicated Urinary Tract Infections pipeline landscape. It covers the p ... Read More

• Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Cognitive Impairment Associated with Schizophrenia-CIAS-Pipeline Insight, 2024 DelveInsight’s, “Cognitive Impairment Associated with Schizophrenia-CIAS- Pipeline Insight, 2024,” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Cognitive Impairment Associated with Sc ... Read More

• Obese patients with Schizophrenia - Pipeline Insight, 2024

  Apr 01, 2024  |  Published by: DelveInsight  |  USD 2,000

  Obese patients with Schizophrenia - Pipeline Insight, 2024 Obese patients with Schizophrenia Overview ""Obese patients with Schizophrenia Pipeline Insight, 2024"" report by DelveInsight outlays comprehensive insights of present clinical development scenario and growth prospects across the Obese pati ... Read More

• Complicated Urinary Tract Infections - Epidemiology Forecast - 2034

  Mar 01, 2024  |  Published by: DelveInsight  |  USD 3,950

  Complicated Urinary Tract Infections - Epidemiology Forecast - 2034 Key Highlights Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated infections to complicated UTIs (cUTIs), pyeloneph ... Read More

• Pulmonary Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 4,250

  Pulmonary Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Pulmonary Drugs Market By Drug Class (Beta-2 Agonists, Corticosteroids, Anticholinergic Agents, Antihistamines, And Others), Indication (Asthma, Chronic Obstructive Pulmonary Disorder (COPD), Cystic Fibrosis, ... Read More

• Pharmacy Automation Systems - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 4,250

  Pharmacy Automation Systems - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Pharmacy Automation Systems Market By Product (Automated Dispensing Systems, Automated Packaging And Labeling Systems, Automated Table-Top Counters, Automated Storage And Retrieval Systems, And Ot ... Read More

• Diabetes Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 4,250

  Diabetes Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Diabetes Drug Market By Drug Type (Insulin, Non-Insulin Drugs, Combination Drugs, And Others), Route Of Administration (Oral, Intravenous, And Subcutaneous), Distribution Channel (Offline And Online) and geogr ... Read More

• Anti-Depressant Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 4,250

  Anti-Depressant Drugs - Global Market Insights, Competitive Landscape, and Market Forecast - 2028 Anti-Depressant Drugs Market By Drug Type (Selective Serotonin Reuptake Inhibitors (SSRI), Selective-Norepinephrine Reuptake Inhibitors (SNRI), Tricyclic Antidepressants (TCA), Monoamine Oxidase Inhibit ... Read More

• Helicobacter Pylori Infection - Pipeline Insight, 2024

  Feb 01, 2024  |  Published by: DelveInsight  |  USD 1,250

  Helicobacter Pylori Infection - Pipeline Insight, 2024 DelveInsight’s, “Helicobacter Pylori Infection - Pipeline Insight, 2024” report provides comprehensive insights about 5+ companies and 5+ pipeline drugs in Helicobacter Pylori Infection pipeline landscape. It covers the pipeline drug profiles, ... Read More

• SOLIRIS Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  SOLIRIS Drug Insight and Market Forecast − 2032 “SOLIRIS Drug Insight and Market Forecast – 2032” report provides comprehensive insights about SOLIRIS for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the SOLIRIS for PNH in the 7MM, i.e., the United Stat ... Read More

• INVELTYS Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  INVELTYS Drug Insight and Market Forecast − 2032 “INVELTYS Drug Insight and Market Forecast – 2032” report provides comprehensive insights about INVELTYS for acute ocular pain (AOP) in the United States. A detailed picture of the INVELTYS for acute ocular pain in the United States for the study peri ... Read More

• EMPAVELI Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  EMPAVELI Drug Insight and Market Forecast − 2032 “EMPAVELI Drug Insight and Market Forecast – 2032” report provides comprehensive insights about EMPAVELI for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the EMPAVELI for PNH in the 7MM, i.e., the United ... Read More

• VXA-A1.1 Emerging Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  VXA-A1.1 Emerging Drug Insight and Market Forecast − 2032 “VXA-A1.1 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about VXA-A1.1 for seasonal influenza in the seven major markets. A detailed picture of the VXA-A1.1 for seasonal influenza in the 7MM, i.e., t ... Read More

• FLUARIX QUADRIVALENT Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 2,750

  FLUARIX QUADRIVALENT Drug Insight and Market Forecast − 2032 “FLUARIX QUADRIVALENT Drug Insight and Market Forecast – 2032” report provides comprehensive insights about FLUARIX QUADRIVALENT for seasonal influenza in the six major markets. A detailed picture of the FLUARIX QUADRIVALENT for seasonal i ... Read More

• DNX-2401 Emerging Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  DNX-2401 Emerging Drug Insight and Market Forecast − 2032 “DNX-2401 Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about DNX-2401 for glioblastoma multiforme (GBM) in the seven major markets. A detailed picture of the DNX-2401 for GBM in the 7MM, i.e., the U ... Read More

• Danicopan Emerging Drug Insight and Market Forecast − 2032

  Nov 01, 2023  |  Published by: DelveInsight  |  USD 3,250

  Danicopan Emerging Drug Insight and Market Forecast − 2032 “Danicopan Emerging Drug Insight and Market Forecast – 2032” report provides comprehensive insights about danicopan for paroxysmal nocturnal hemoglobinuria (PNH) in the seven major markets. A detailed picture of the danicopan for PNH in the ... Read More

< prev 1 2 3 4 5 6 7 8 9 10 next >